{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:38:27Z","timestamp":1747147107636,"version":"3.40.5"},"reference-count":50,"publisher":"Wiley","issue":"21","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID\u201019 pandemic continues to pose challenges to the treatment of hemato\u2010oncology patients. Emergence of COVID\u201019 variants, availability of vaccine boosters and antiviral treatments could impact their outcome. We retrospectively studied patients with hematologic malignancies and confirmed COVID\u201019 during the Omicron outbreak. Of 116 evaluated patients, 16% developed severe or critical COVID\u201019. Diagnosis of chronic lymphocytic leukemia (CLL) was significantly associated with severe COVID\u201019 (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). The vaccine effectiveness was related to the timing of the vaccine, with patients who received a mRNA vaccine within 7\u201390\u2009days prior to COVID\u201019 being less likely to develop severe disease compared to all other patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.019). There was no correlation between disease severity and antiviral therapies. Importantly, 45% of patients undergoing active hematological treatment had to interrupt their treatment due to COVID\u201019. In conclusion, patients with hematologic malignancies are at a considerable risk for severe COVID\u201019 during the Omicron outbreak, with patients with CLL being the most vulnerable. mRNA vaccines have the potential to protect hematological patients from severe COVID\u201019 if administered within the previous 3\u2009months. Hematological treatment interruption is a frequent adverse outcome of COVID\u201019 infection.<\/jats:p>","DOI":"10.1002\/cam4.6397","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T09:34:43Z","timestamp":1698226483000},"page":"20503-20510","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Timing of <scp>BNT162b2<\/scp> vaccine prior to <scp>COVID<\/scp>\u201019 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study"],"prefix":"10.1002","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-099X","authenticated-orcid":false,"given":"Odit","family":"Gutwein","sequence":"first","affiliation":[{"name":"Department of Hematology Shamir Medical Center (Assaf Harofeh)  Zerifin Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University  Tel Aviv\u2010Yafo Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Herzog\u00a0Tzarfati","sequence":"additional","affiliation":[{"name":"Department of Hematology Shamir Medical Center (Assaf Harofeh)  Zerifin Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Apel","sequence":"additional","affiliation":[{"name":"Department of Hematology Shamir Medical Center (Assaf Harofeh)  Zerifin Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-886X","authenticated-orcid":false,"given":"Naomi","family":"Rahimi\u2010Levene","sequence":"additional","affiliation":[{"name":"Department of Hematology Shamir Medical Center (Assaf Harofeh)  Zerifin Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levy","family":"Ilana","sequence":"additional","affiliation":[{"name":"Hematology Unit Bnai Zion Medical Center  Haifa Israel"},{"name":"Faculty of Medicine Technion\u2010Israel Institute of Technology  Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3435-8612","authenticated-orcid":false,"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[{"name":"Hematology Unit Bnai Zion Medical Center  Haifa Israel"},{"name":"Faculty of Medicine Technion\u2010Israel Institute of Technology  Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Koren\u2010Michowitz","sequence":"additional","affiliation":[{"name":"Department of Hematology Shamir Medical Center (Assaf Harofeh)  Zerifin Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University  Tel Aviv\u2010Yafo Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30442-3"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1966782"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006333"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26284"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0222"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100984"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.3227"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00364-3"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c01451"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33233-9"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0308"},{"key":"e_1_2_10_13_1","unstructured":"Coronavirus (COVID\u201019).Update: FDA Authorizes First Oral Antiviral for Treatment of COVID\u201019 | FDA. Accessed November 18 20222022.https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/coronavirus\u2010covid\u201019\u2010update\u2010fda\u2010authorizes\u2010first\u2010oral\u2010antiviral\u2010treatment\u2010covid\u201019"},{"key":"e_1_2_10_14_1","unstructured":"Fourth Dose of the Vaccine Approved for People with a Weakened Immune System.Ministry of Health. Accessed November 22 20222022https:\/\/www.gov.il\/en\/departments\/news\/30122021\u201005"},{"key":"e_1_2_10_15_1","unstructured":"SARS\u2010CoV\u20102 sequences by variant.2022. Accessed November 22 2022.https:\/\/ourworldindata.org\/grapher\/covid\u2010variants\u2010bar?time=2022\u201001\u201024&country=USA~GBR~ESP~ZAF~ITA~DEU~FRA~CAN~BEL~AUS"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_2_10_17_1","unstructured":"COVID\u201019 Treatment Guidelines. Accessed December 21 20222022.https:\/\/www.covid19treatmentguidelines.nih.gov\/"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003170"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174252"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2086249"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.04.015"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194629"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3064"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(20)30687-X"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13722"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-716977"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01450-8"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010158757"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17927"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01675-1"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i1.1"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101765"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.7382"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-067873"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac501"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201570"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17990-7"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119451"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7142a4"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01586-0"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac443"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116846"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17140"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2998"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.38354"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100743"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.6397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T18:47:38Z","timestamp":1700678858000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.6397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":50,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1002\/cam4.6397"],"URL":"https:\/\/doi.org\/10.1002\/cam4.6397","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"type":"print","value":"2045-7634"},{"type":"electronic","value":"2045-7634"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"2023-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}